| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0469-2660-30 | 0469-2660 | HUMAN PRESCRIPTION DRUG | VEOZAH | fezolinetant | TABLET, FILM COATED | ORAL | 20230512 | N/A | NDA | NDA216578 | Astellas Pharma US, Inc. | FEZOLINETANT | 45 mg/1 | 1 BOTTLE in 1 CARTON (0469-2660-30) / 30 TABLET, FILM COATED in 1 BOTTLE |
| 0469-2660-90 | 0469-2660 | HUMAN PRESCRIPTION DRUG | VEOZAH | fezolinetant | TABLET, FILM COATED | ORAL | 20230512 | N/A | NDA | NDA216578 | Astellas Pharma US, Inc. | FEZOLINETANT | 45 mg/1 | 1 BOTTLE in 1 CARTON (0469-2660-90) / 90 TABLET, FILM COATED in 1 BOTTLE |
| 0469-2460-28 | 0469-2460 | HUMAN PRESCRIPTION DRUG | VEOZAH | fezolinetant | TABLET, FILM COATED | ORAL | 20230516 | N/A | NDA | NDA216578 | Astellas Pharma US, Inc. | FEZOLINETANT | 45 mg/1 | 4 CARTON in 1 TRAY (0469-2460-28) / 1 BOTTLE in 1 CARTON (0469-2460-07) / 7 TABLET, FILM COATED in 1 BOTTLE |
| 0469-2760-28 | 0469-2760 | HUMAN PRESCRIPTION DRUG | VEOZAH | fezolinetant | TABLET, FILM COATED | ORAL | 20230512 | N/A | NDA | NDA216578 | Astellas Pharma US, Inc. | FEZOLINETANT | 45 mg/1 | 4 CARTON in 1 TRAY (0469-2760-28) / 1 BLISTER PACK in 1 CARTON (0469-2760-07) / 7 TABLET, FILM COATED in 1 BLISTER PACK |